Replies to post #72905 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

This will not reduce care costs - takes too many man hours and can't be done by patient. "personalized" programs are not easily replicated in the real world.

Scientists at the Buck Institute for Research on Aging recently demonstrated that memory loss for patients with early Alzheimer’s disease can be reversed — a feat the research team managed through a 36-point approach called metabolic enhancement for neurodegeneration.

The multidisciplinary program is the first to show that cognitive decline and memory loss can be reversed – changing the foundations of how Alzheimer’s disease is viewed.

The program, described in the journal Aging, is a 36-point personalized approach involving diet changes, vitamin supplements, exercise, better sleep, brain stimulation, specific drugs, and several more steps that effect (sic) brain chemistry.

https://alzheimersnewstoday.com/2016/06/21/multidisciplinary-program-reversed-early-cognitive-decline-dramatically-improving-cognition/

Are you extrapolating the reported encouraging evidence that previously reported positive trends in certain cognitive and biologic measures persisted over a period of approximately 31 weeks to mean the the drug has been proven to reverse cognitive decline?

No, I'm talking about the piano player, the painter, the golfer, and the mass transit user.

Your 2008 reference to Enbrel sounds like a real party, where's the link to P3? Never made it? Side effects?

Enbrel® is NOT a drug one would take unless it is critically needed. That is because when administered systemically, it increases the potential risks of infection, low blood counts, lymphoma, demyelinating nerve disease, eye inflammation, congestive heart failure, and death.73 The long-term side effects are not known when Enbrel® is administered primarily to the brain, as is being done in this anti-Alzheimer’s treatment.

Written informed consent has been obtained from all these Alzheimer’s disease test subjects (or their family members) warning them of these potential risks. The rationale in accepting known and unknown side effect risks is that Alzheimer’s disease is a uniformly progressive and lethal disease. There is no other therapy that so rapidly and effectively reverses the clinical course of the disease.

http://www.lifeextension.com/magazine/2008/8/novel-drug-therapy-immediately-reverses-alzheimers-cognitive-deficits/page-01